Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis

Clinical Cancer Research

Volumn 8, Issue 1, 2002, Pages 61-74

  Urquidi, Virginia ^a   Sloan, Derek ^a   Kawai, Kanji ^a   Agarwal, Dianne ^a   Tarin, David ^a   Goodison, Steve ^a   Woodman, Anthony C ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CRANFIELD UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOPONTIN; THROMBOSPONDIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CANCER TRANSPLANTATION; CARCINOGENIC ACTIVITY; CELL CLONE; CELL TRANSFORMATION; FEMALE; GENETIC SCREENING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KARYOTYPE; LUNG METASTASIS; METASTASIS; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RNA ANALYSIS;

ANIMALS; ANTIGENS, CD44; BREAST NEOPLASMS; CELL DIVISION; CELL SURVIVAL; DISEASE PROGRESSION; DNA PRIMERS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; KARYOTYPING; LUNG NEOPLASMS; MICE; MICE, NUDE; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; OSTEOPONTIN; PHENOTYPE; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIALOGLYCOPROTEINS; THROMBOSPONDIN 1; TUMOR MARKERS, BIOLOGICAL;

EID: 0036156751     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (76)

1. Clinical and experimental studies on the biology of metastasis
2. Recent advances in the study of tumour invasion and metastasis
3. Host and tumour factors in cancer metastasis
4. Molecular determinants of angiogenesis in cancer metastasis
5. Mechanisms of human tumor metastasis studied in patients with peritoneovenous shunts
6. Metastasis: Quantitative analysis of distribution and fate of tumor emboli labeled with 125 I-5-iodo-2′-deoxyuridine
7. Molecular mechanisms for organ-specific colon carcinoma metastasis
8. Rationale and methods for the use of nude mice to study the biology and therapy of human cancer metastasis
9. Orthotopic implantation of human colon carcinomas into nude mice provides a valuable model for the biology and therapy of metastasis
10. Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice
11. In vivo selection and characterization of metastatic variants from human pancreatic adenocarcinoma by using orthotopic implantation in nude mice
12. Integrin expression in human melanoma cells with differing invasive and metastatic properties
13. Long-term human breast carcinoma cell lines of metastatic origin: Preliminary characterization
14. Multicolor spectral karyotyping of human chromosomes
15. Spectral karyotyping, a 24-colour FISH technique for the identification of chromosomal rearrangements
16. Real time quantitative PCR
17. Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: Comparison of endpoint and real-time methods
18. Validation of array-based gene expression profiles by real-time (kinetic) RT-PCR
19. Biochemical properties of glycoproteins involved in lymphocyte recognition of high endothelial venules in man
20. Comparison of telomerase and CD44 expression as diagnostic tumor markers in lesions of the thyroid
21. Noninvasive diagnosis of bladder carcinoma by enzyme-linked immunosorbent assay detection of CD44 isoforms in exfoliated urothelia
22. Multiple intron retention occurs in tumor cell CD44 mRNA processing
23. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors
24. Microvessel quantitation in invasive breast cancer by staining for factor VIII-related antigen
25. Rapid analysis of distinctive CD44 RNA splicing preferences that characterize colonic tumors
26. Clinical implications of anomalous CD44 gene expression in neoplasia
27. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells
28. The two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: Each one individually suffices to confer metastatic behavior
29. Soluble CD44 v5 and v6 in serum of patients with breast cancer. Correlation with expression of CD44 v5 and v6 variants in primary tumors and location of distant metastasis
30. Soluble CD44 splice variants in metastasizing human breast cancer
31. Specific reduction in osteopontin synthesis by antisense RNA inhibits the tumorigenicity of transformed Ratl fibroblasts
32. Expression of antisense osteopontin RNA inhibits tumor promoter-induced neoplastic transformation of mouse JB6 epidermal cells
33. The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model
34. Metastasis results from preexisting variant cells within a malignant tumor
35. Tumor heterogeneity and the biology of cancer invasion and metastasis
36. The pathogenesis of cancer metastasis
37. Tumor cell diversity and host responses in cancer metastasis - Part I - Properties of metastatic cells
38. An approach to studying the cellular properties associated with metastasis: Some in vitro properties of tumor variants selected in vivo for enhanced metastasis
39. Dual inactivation of RB and p53 pathways in RAS-induced melanomas
40. Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor β growth arrest program
41. The cadherin-catenin system: Implications for growth and differentiation of endocrine tissues
42. Estradiol regulates E-cadherin mRNA levels in the surface epithelium of the mouse ovary
43. Endothelial cells and angiogenic growth factors in cancer growth and metastasis. Introduction
44. Thrombospondin-1 suppresses wound healing and granulation tissue formation in the skin of transgenic mice
45. Molecular aspects of tumor cell invasion and metastasis
46. Matrix metalloproteinases: Multifunctional contributors to tumor progression
47. Analysis of anomalous CD44 gene expression in human breast, bladder, and colon cancer and correlation of observed mRNA and protein isoforms
48. The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells
49. CD44 splice variants confer metastatic behavior in rats: Homologous sequences are expressed in human tumor cell lines
50. A link between ras and metastatic behavior of tumor cells: Ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells
51. Isolation and characterization of human melanoma cell variants expressing high and low levels of CD44
52. Distinct effects of two CD44 isoforms on tumor growth in vivo
53. Targeted disruption of CD44 in MDAY-D2 lymphosarcoma cells has no effect on subcutaneous growth or metastatic capacity
54. Diversity of function is inherent in matricellular proteins: An appraisal of thrombospondin 1
55. The functions of thrombospondin-1 and -2
56. Transfection of thrombospondin I complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis
57. A human fibrosarcoma inhibits systemic angiogenesis and the growth of experimental metastases via thrombospondin-1
58. A secreted phosphoprotein marker for neoplastic transformation of both epithelial and fibroblastic cells
59. Secreted phosphoproteins associated with neoplastic transformation: Close homology with plasma proteins cleaved during blood coagulation
60. Reduced malignancy of ras-transformed NIH 3T3 cells expressing antisense osteopontin RNA
61. Osteopontin expression and distribution in human carcinomas
62. Osteopontin expression in a group of lymph node negative breast cancer patients
63. Tumor cells are the source of osteopontin and bone sialoprotein expression in human breast cancer
64. The LCC 15-MB human breast cancer cell line expresses osteopontin and exhibits an invasive and metastatic phenotype
65. Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells
66. Intracellular signalling: Phosphatidylinositol lipid metabolism in cancer cells
67. Receptor-ligand interaction between CD44 and osteopontin (Eta-1)
68. Suppression of metastasis in human breast carcinoma MDA-MB-435 cells after transfection with the metastasis suppressor gene, KiSS-1
69. Functional evidence for a novel human breast carcinoma metastasis suppressor, BRMSI, encoded at chromosome 11q13
70. KAI1, a putative marker for metastatic potential in human breast cancer
71. Correlation between reduction of metastasis in the MDA-MB-435 model system and increased expression of the Kaiprotein
72. Genomic organization of the human KAI1 metastasis-suppressor gene
73. Identification and characterization of differentially expressed genes in tumor metastasis: The nm23 gene
74. Transfection of human nm23-Hinto the human MDA-MB-435 breast carcinoma cell line: Effects on tumor metastatic potential, colonization and enzymatic activity
75. Suppression of MDA-MB-435 breast carcinoma cell metastasis following the introduction of human chromosome 11
76. Genomic analysis of metastasis reveals an essential role for RhoC